Loss of NRP1 enhances cigarette-smoke-induced emphysema [33], facilitates NE uptake in breast cancer cells and resulting cytotoxicity [34,35], and serves as a co-receptor for ACE-2 during COVID-19 infection [36]. Here, ACE2 is linked to pulmonary emphysema.